ストックスクリーナーアプリを入手
18.89
0.45%
0.10
前日終値:
$18.79
開ける：
$18.74
24時間の取引高:
176.80K
Relative Volume:
0.41
時価総額：
$526.04M
収益：
$242.12M
当期純損益:
$-351.72M
株価収益率:
-1.4214
EPS:
-13.29
ネットキャッシュフロー:
$24.82M
1週間 パフォーマンス:
+0.83%
1か月 パフォーマンス:
+91.82%
6か月 パフォーマンス:
+36.38%
1年 パフォーマンス:
-7.48%
1日の値動き範囲:
$18.74
$18.89
1週間の範囲:
$18.65
$18.95
52週間の値動き範囲:
$8.15
$19.44
Zimvie Inc Stock (ZIMV) Company Profile
ZIMV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
18.89 | 532.43M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
127.33 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.81 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
378.96 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.28 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.03 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-22 | アップグレード | Barclays | Underweight → Equal Weight |
| 2025-04-10 | 開始されました | B. Riley Securities | Buy |
| 2025-03-13 | ダウングレード | Needham | Buy → Hold |
| 2024-05-16 | アップグレード | Needham | Hold → Buy |
| 2023-11-16 | 開始されました | Needham | Hold |
| 2022-12-21 | 開始されました | Barclays | Underweight |
| 2022-06-17 | 開始されました | JP Morgan | Neutral |
| 2022-03-18 | 開始されました | Guggenheim | Neutral |
すべてを表示
Zimvie Inc (ZIMV) 最新ニュース
What is the risk reward ratio of investing in ZimVie Inc. stockBreakout Stocks Tips For Beginners - jammulinksnews.com
What makes ZimVie Inc. stock price move sharplyStock Market Forecasts From AI Tools - jammulinksnews.com
How does ZimVie Inc. generate profit in a changing economyMarket Forecast Signals For Fast Growth - jammulinksnews.com
ZimVie (ZIMV) Q2 EPS Doubles to $0.26 - AOL.com
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news By Investing.com - Investing.com South Africa
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news - Investing.com Nigeria
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - TipRanks
ZimVie Tops Estimates But Preps For ARCHIMED Buyout - Finimize
ZimVie earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Using RSI to spot recovery in ZimVie Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
ZimVie Reports Second Quarter 2025 Financial Results - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
ZimVie Inc. Forms Bullish Flag — Upside AheadLow Risk Equity Screener With Results Shared - metal.it
ZimVie’s Discounted Stock Draws Buyout Bids And Investor Caution - Finimize
ZimVie Inc. Sees Relief Buying After Extended DropReversal Alert Based on RSI Indicator Confirmed - metal.it
Published on: 2025-07-29 00:19:04 - metal.it
What institutions are buying ZimVie Inc. stock nowFast Gaining Stock Screener Reports Released - beatles.ru
What catalysts could drive ZimVie Inc. stock higher in 2025Capitalize on proven trading setups - jammulinksnews.com
What are the technical indicators suggesting about ZimVie Inc.Free Stock Market Forecast Reports - jammulinksnews.com
What are the latest earnings results for ZimVie Inc.Free Trend-Following Techniques - jammulinksnews.com
Is ZimVie Inc. a growth stock or a value stockFree Investment Case Studies - jammulinksnews.com
What is ZimVie Inc. company’s growth strategyBuild wealth faster with consistent growth stocks - jammulinksnews.com
What institutional investors are buying ZimVie Inc. stockGain access to exclusive stock analysis - jammulinksnews.com
What are analysts’ price targets for ZimVie Inc. in the next 12 monthsFree Risk Assessment Services - jammulinksnews.com
Is ZimVie Inc. Stock a Smart Buy in 2025 Investment Analysis InsideRisk Adjusted Stock Signals - metal.it
ZimVie to Announce Q2 Results July 30 - Dentistry Today
ZimVie withdraws guidance amid ARCHIMED transaction - TipRanks
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - The Manila Times
ZimVie Sets Final Public Earnings Date Before $19/Share ARCHIMED Takeover - Stock Titan
Hold Rating Maintained on ZimVie Inc Amid Acquisition by ARCHIMED - TipRanks
What drives ZimVie Inc. stock priceGame-changing returns - Autocar Professional
ZIMV Expands Reach in China Through Osstem Implant Partnership | - GuruFocus
ZimVie inks exclusive dental implant distro deal with Osstem in China - MassDevice
ZimVie Doubles — And Then Some — On Its Second Takeover Deal - MSN
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China - The Manila Times
ZimVie partners with Osstem Implant to expand in Chinese dental market - Investing.com
ZimVie partners with Osstem Implant to expand in Chinese dental market By Investing.com - Investing.com South Africa
ZimVie Inc. Enters Strategic Distribution Agreement with Osstem Implant to Expand Presence in China’s Dental Implant Market - Nasdaq
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System - sg.finance.yahoo.com
ZimVie Targets Massive 10M Unit Chinese Dental Market Through Exclusive Osstem Partnership - Stock Titan
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
Is ZimVie Inc. a good long term investmentFree Popular Stock Recommendations - jammulinksnews.com
ZimVie Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc.ZIMV - The Globe and Mail
User - FinancialContent
Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers - insights.citeline.com
ARCHIMED To Buy ZimVie In $730 Million Deal - Pulse 2.0
ZimVie upgraded to Equal Weight from Underweight at Barclays - TipRanks
ZimVie to sell to investment firm for about $730M - MedTech Dive
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger By Investing.com - Investing.com Nigeria
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger - Investing.com Australia
Zimvie Inc (ZIMV) 財務データ
収益
当期純利益
現金流量
EPS
Zimvie Inc (ZIMV) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
| Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
| Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
| Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
| Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
| Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
| Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
| Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
| Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
| Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
0.74%
0.03%
大文字化:
|
ボリューム (24 時間):